HNRNPK and chronic myelogenous leukemia, BCR-ABL1 positive: hnRNP K and PCBP2, as oncogenes, contribute to the progression of CML-CP to CML-BC via distinct pathways through the activation of MYC mRNA translation and suppression of C/EBP α mRNA translation (58).